Although increased synaptic release has been suggested to contribute to raised glutamate levels, strong evidence supports the involvement of the glutamate transporter EAAT2, with studies demonstrating reduced EAAT2 expression in different ALS models, including in SOD1 mice [64, 77, 164, 167, 203]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.